TrialInvestigational new drugs2025

Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study.

Yi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.